IP Library Granted Patent US 7,265,186
Granted Patent B2
US 7,265,186 · App. 10/984,679 · Granted Sep 4, 2007

Multi-arm block copolymers as drug delivery vehicles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,265,186
App. No.
10/984,679
Granted
Sep 4, 2007
Kind
B2
Abstract

The invention provides methods for making copolymers and multi-arm block copolymers useful as drug delivery vehicles. The multi-arm block copolymers comprise a central core molecule, such as a residue of a polyol, and at least three copolymer arms covalently attached to the central core molecule, each copolymer arm comprising an inner hydrophobic polymer segment covalently attached to the central core molecule and an outer hydrophilic polymer segment covalently attached to the hydrophobic polymer segment, wherein the central core molecule and the hydrophobic polymer segment define a hydrophobic core region. The solubility of hydrophobic biologically active agents can be improved by entrapment within the hydrophobic core region of the block copolymer. The invention further includes pharmaceutical compositions including such block copolymers, pharmaceutical compositions, and methods of using the block copolymers as drug delivery vehicles.

Claims (81)

1. A method of preparing a pharmaceutical composition, comprising:

providing a multi-arm block copolymer, the block copolymer comprising a central core molecule comprising a residue of a polyol, and at least three copolymer arms covalently attached to the central core molecule, each copolymer arm comprising an inner hydrophobic polymer segment covalently attached to the central core molecule and an outer hydrophilic polymer segment covalently attached to the hydrophobic polymer segment, wherein the central core molecule and the hydrophobic polymer segment define a hydrophobic core region, and

entrapping a biologically active agent within the hydrophobic core region of the multi-arm block copolymer.

2. The method of claim 1 , wherein said entrapping step comprises dissolving the multi-arm block copolymer and biologically active agent in an organic solvent to form a mixture and drying the mixture to form a solid pharmaceutical composition.

3. The method of claim 1 , wherein said entrapping step comprises suspending the biologically active agent in an aqueous solution of the multi-arm block copolymer and subjecting the solution to ultrasonication.

4. The method of claim 1 , wherein said entrapping step comprises mixing the biologically active agent and multi-arm block copolymer in solid form, heating the mixture to form a melt, and stirring the mixture to intimately mix the biologically active moiety and the multi-arm block copolymer.

5. The method of claim 1 , wherein said biologically active agent is selected from the group consisting of 3,4-di-[1-methyl 6-nitro-3-indolyl]-1H-pyrrole-2,5-dione (MNIPD), simvastatin, indomethacin, pivaloyloxymethyl butyrate, cyclosporin A, paclitaxel, analogs thereof, and pharmaceutically acceptable salts thereof.

6. The method of claim 1 , wherein said central core molecule is a residue of a polyol selected from the group consisting of glycerol, sorbitol, pentaerythritol, and glycerol oligomers.

7. The method of claim 1 , wherein said central core molecule is a residue of hexaglycerol.

8. The method of claim 1 , wherein said central core molecule is a residue of hydroxypropyl-β-cyclodextrin.

9. The method of claim 1 , wherein said inner hydrophobic polymer segment is selected from the group consisting of a poly(hydroxyester), a poly(alkylene oxide) other than poly(ethylene glycol), or a copolymer thereof.

10. The method of claim 1 , wherein said inner hydrophobic polymer segment is poly(propylene glycol).

11. The method of claim 1 , wherein said inner hydrophobic polymer segment is a poly(hydroxyester) selected from the group consisting of poly(lactide), poly(glycolide), poly(lactide)/(glycolide) copolymer, poly(butyrolactide), and polycaprolactone.

12. The method of claim 1 , wherein said outer hydrophilic polymer segment comprises poly(ethylene glycol).

13. The method of claim 1 , wherein each hydrophobic and hydrophilic polymer segment has a molecular weight of about 500 Da to about 100,000 Da.

14. The method of claim 1 , wherein said hydrophobic polymer segment has a molecular weight of about 10,000 Da to about 40,000 Da.

15. The method of claim 1 , wherein said outer hydrophilic polymer segment has a molecular weight of about 1,000 Da to about 20,000 Da.

16. The method of claim 1 , wherein said central core molecule is attached to at least 5 copolymer arms.

17. The method of claim 1 , wherein said central core molecule is attached to at least 8 copolymer arms.

18. The method of claim 1 , wherein said central core molecule is attached to at least 10 copolymer arms.

19. The method of claim 1 , wherein at least one targeting moiety is covalently attached to at least one hydrophilic polymer segment.

20. The method of claim 1 , wherein the targeting moiety is a bisphosphonate.

21. The method of claim 1 , wherein at least one capping group is covalently attached to at least one hydrophilic polymer segment.

22. The method of claim 21 , wherein said capping group is selected from the group consisting of alkoxy, hydroxyl, protected hydroxyl, active ester, active carbonate, acetal, aldehyde, aldehyde hydrates, alkyl or aryl sulfonate, halide, disulfide, alkenyl, acrylate, methacrylate, acrylamide, active sulfone, amine, protected amine, hydrazide, protected hydrazide, thiol, protected thiol, carboxylic acid, protected carboxylic acid, isocyanate, isothiocyanate, maleimide, vinylsulfone, dithiopyridine, vinylpyridine, iodoacetamide, epoxide, glyoxals, diones, mesylates, tosylates, or tresylate.

23. The method of claim 1 , wherein the multi-arm block copolymer has a structure:

A(—O—B—O—C-D) n

wherein:

A is a central core molecule comprising a residue of a polyol,

O is oxygen,

B is a hydrophobic polymer segment,

C is a hydrophilic polymer segment,

D is a capping group,

and n is 3 to about 25.

24. The method of claim 23 , wherein each D is alkoxy.

25. The method of claim 23 , wherein each D is hydroxy.

26. The method of claim 23 , wherein each D is selected from the group consisting of alkoxy, hydroxyl, protected hydroxyl, active ester, active carbonate, acetal, aldehyde, aldehyde hydrates, alkyl or aryl sulfonate, halide, disulfide, alkenyl, acrylate, methacrylate, acrylamide, active sulfone, amine, protected amine, hydrazide, protected hydrazide, thiol, protected thiol, carboxylic acid, protected carboxylic acid, isocyanate, isothiocyanate, maleimide, vinylsulfone, dithiopyridine, vinylpyridine, iodoacetamide, epoxide, glyoxals, diones, mesylates, tosylates, or tresylate.

27. The method of claim 23 , wherein A is a residue of a polyol selected from the group consisting of glycerol, sorbitol, pentaerythritol, hydroxypropyl-β-cyclodextrin, and glycerol oligomers.

28. The method of claim 23 , wherein B is selected from the group consisting of a poly(hydroxyester), a poly(alkylene oxide) other than poly(ethylene glycol), or a copolymer thereof.

29. The method of claim 23 , wherein B is poly(propylene oxide).

30. The method of claim 23 , wherein B is a poly(hydroxyester) selected from the group consisting of poly(lactide), poly(glycolide), poly(lactide)/(glycolide) copolymer, poly(butyrolactide), and polycaprolactone.

31. The method of claim 23 , wherein at least one of B and C comprises at least one degradable linkage.

32. The method of claim 23 , wherein C comprises poly(ethylene glycol).

33. The method of claim 23 , wherein C comprises a hydrolyzable linkage selected from the group consisting of esters, carbonates, imines, hydrazone, phosphate esters, orthoesters, peptides, or acetals.

34. The method of claim 1 , wherein the multi-arm block copolymer has a structure:

(E-C—O—B—O—) p A(—O—B—O—C-D) m

wherein:

A is a central core molecule moiety comprising a residue of a polyol,

O is oxygen,

B is a hydrophobic polymer segment,

C is a hydrophilic polymer segment,

D is a hydroxyl or alkoxy group,

p is at least 1,

the sum of m and p is from 3 to about 25, and

E is a functional group selected from the group consisting of active ester, active carbonate, acetal, aldehyde, aldehyde hydrates, alkyl or aryl sulfonate, halide, disulfide, alkenyl, acrylate, methacrylate, acrylamide, active sulfone, amine, protected amine, hydrazide, protected hydrazide, thiol, protected thiol, carboxylic acid, protected carboxylic acid, isocyanate, isothiocyanate, maleimide, vinylsulfone, dithiopyridine, vinylpyridine, iodoacetamide, epoxide, glyoxals, diones, mesylates, tosylates, or tresylate.

35. The method of claim 1 , wherein the multi-arm block copolymer has a structure:

(T-C—O—B—O—) p A(—O—B—O—C-D) m

wherein:

A is a central core molecule moiety comprising a residue of a polyol,

O is oxygen,

B is a hydrophobic polymer segment,

C is a hydrophilic polymer segment,

D is a capping group,

p is at least 1,

the sum of m and p is from 3 to about 25, and

T is a targeting moiety.

36. The method of claim 35 , wherein T is selected from the group consisting of a protein, an antibody, an antibody fragment, a peptide, a carbohydrate, a lipid, an oligonucleotide, DNA, RNA, and a small molecule having molecular weight less than 2000 Daltons.

37. The method of claim 35 , wherein T is a bisphosphonate.

38. The method of claim 1 , wherein the multi-arm block copolymer comprises:

a central core molecule comprising a residue of a polyol, and

at least five copolymer arms covalently attached to the central core molecule, each copolymer arm comprising an inner hydrophobic polymer segment covalently attached to the central core molecule and an outer hydrophilic polymer segment covalently attached to the hydrophobic polymer segment,

wherein the central core molecule and the hydrophobic polymer segment define a hydrophobic core region.

39. The method of claim 38 , wherein said central core molecule is a residue of a polyol selected from the group consisting of glycerol, sorbitol, pentaerythritol, and glycerol oligomers.

40. The method of claim 38 , wherein said inner hydrophobic polymer segment is selected from the group consisting of a poly(hydroxyester), a poly(alkylene oxide) other than poly(ethylene glycol), or a copolymer thereof.

41. The method of claim 38 , wherein said inner hydrophobic polymer segment is a poly(hydroxyester) selected from the group consisting of poly(lactide), poly(glycolide), poly(lactide)/(glycolide) copolymer, and polycaprolactone.

42. The method of claim 38 , wherein at least one of the inner hydrophobic polymer segment and the outer hydrophilic polymer segment comprises at least one degradable linkage.

43. The method of claim 38 , wherein said outer hydrophilic polymer segment comprises poly(ethylene glycol).

44. The method of claim 38 , wherein said central core molecule is attached to at least 8 copolymer arms.

45. The method of claim 38 , wherein said central core molecule is attached to at least 10 copolymer arms.

46. The method of claim 38 , wherein at least one targeting moiety is covalently attached to at least one hydrophilic polymer segment.

47. The method of claim 38 , wherein at least one capping group is covalently attached to at least one hydrophilic polymer segment.

48. The method of claim 47 , wherein the capping group is selected from the group consisting of alkoxy, hydroxyl, protected hydroxyl, active ester, active carbonate, acetal, aldehyde, aldehyde hydrates, alkyl or aryl sulfonate, halide, disulfide, alkenyl, acrylate, methacrylate, acrylamide, active sulfone, amine, protected amine, hydrazide, protected hydrazide, thiol, protected thiol, carboxylic acid, protected carboxylic acid, isocyanate, isothiocyanate, maleimide, vinylsulfone, dithiopyridine, vinylpyridine, iodoacetamide, epoxide, glyoxals, diones, mesylates, tosylates, or tresylate.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
MERGER Recorded Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2005
From: ZHAO, XUAN
To: NEKTAR THERAPEUTICS AL, CORPORATION
Reel/Frame 015913/0120 →